BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 27903721)

  • 1. Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice.
    Ledo JH; Azevedo EP; Beckman D; Ribeiro FC; Santos LE; Razolli DS; Kincheski GC; Melo HM; Bellio M; Teixeira AL; Velloso LA; Foguel D; De Felice FG; Ferreira ST
    J Neurosci; 2016 Nov; 36(48):12106-12116. PubMed ID: 27903721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial dysfunction connects depression and Alzheimer's disease.
    Santos LE; Beckman D; Ferreira ST
    Brain Behav Immun; 2016 Jul; 55():151-165. PubMed ID: 26612494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model.
    Diniz LP; Tortelli V; Matias I; Morgado J; Bérgamo Araujo AP; Melo HM; Seixas da Silva GS; Alves-Leon SV; de Souza JM; Ferreira ST; De Felice FG; Gomes FCA
    J Neurosci; 2017 Jul; 37(28):6797-6809. PubMed ID: 28607171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease.
    Balducci C; Frasca A; Zotti M; La Vitola P; Mhillaj E; Grigoli E; Iacobellis M; Grandi F; Messa M; Colombo L; Molteni M; Trabace L; Rossetti C; Salmona M; Forloni G
    Brain Behav Immun; 2017 Feb; 60():188-197. PubMed ID: 27751869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate Immunity Fights Alzheimer's Disease.
    Guillot-Sestier MV; Doty KR; Town T
    Trends Neurosci; 2015 Nov; 38(11):674-681. PubMed ID: 26549882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-β oligomers in mice.
    Kincheski GC; Valentim IS; Clarke JR; Cozachenco D; Castelo-Branco MTL; Ramos-Lobo AM; Rumjanek VMBD; Donato J; De Felice FG; Ferreira ST
    Brain Behav Immun; 2017 Aug; 64():140-151. PubMed ID: 28412140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.
    Brito-Moreira J; Lourenco MV; Oliveira MM; Ribeiro FC; Ledo JH; Diniz LP; Vital JFS; Magdesian MH; Melo HM; Barros-Aragão F; de Souza JM; Alves-Leon SV; Gomes FCA; Clarke JR; Figueiredo CP; De Felice FG; Ferreira ST
    J Biol Chem; 2017 May; 292(18):7327-7337. PubMed ID: 28283575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease.
    Vargas LM; Cerpa W; Muñoz FJ; Zanlungo S; Alvarez AR
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1148-1159. PubMed ID: 29378302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation.
    Clarke JR; Lyra E Silva NM; Figueiredo CP; Frozza RL; Ledo JH; Beckman D; Katashima CK; Razolli D; Carvalho BM; Frazão R; Silveira MA; Ribeiro FC; Bomfim TR; Neves FS; Klein WL; Medeiros R; LaFerla FM; Carvalheira JB; Saad MJ; Munoz DP; Velloso LA; Ferreira ST; De Felice FG
    EMBO Mol Med; 2015 Feb; 7(2):190-210. PubMed ID: 25617315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
    Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
    J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
    Webers A; Heneka MT; Gleeson PA
    Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice.
    Paouri E; Tzara O; Kartalou GI; Zenelak S; Georgopoulos S
    J Neurosci; 2017 May; 37(20):5155-5171. PubMed ID: 28442538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.
    Cline EN; Bicca MA; Viola KL; Klein WL
    J Alzheimers Dis; 2018; 64(s1):S567-S610. PubMed ID: 29843241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.
    Jana M; Palencia CA; Pahan K
    J Immunol; 2008 Nov; 181(10):7254-62. PubMed ID: 18981147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional Superparamagnetic Iron Oxide Nanoparticles Conjugated with Aβ Oligomer-Specific scFv Antibody and Class A Scavenger Receptor Activator Show Early Diagnostic Potentials for Alzheimer's Disease.
    Liu XG; Zhang L; Lu S; Liu DQ; Zhang LX; Yu XL; Liu RT
    Int J Nanomedicine; 2020; 15():4919-4932. PubMed ID: 32764925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
    Yang J; Wise L; Fukuchi KI
    Front Immunol; 2020; 11():724. PubMed ID: 32391019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function.
    Marsh SE; Abud EM; Lakatos A; Karimzadeh A; Yeung ST; Davtyan H; Fote GM; Lau L; Weinger JG; Lane TE; Inlay MA; Poon WW; Blurton-Jones M
    Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1316-25. PubMed ID: 26884167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
    Regen F; Hellmann-Regen J; Costantini E; Reale M
    Curr Alzheimer Res; 2017; 14(11):1140-1148. PubMed ID: 28164764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.